Financial reports
10-Q
2024 Q3
Quarterly report
22 Mar 24
NT 10-Q
Notice of late quarterly filing
18 Mar 24
10-Q
2024 Q2
Quarterly report
19 Dec 23
NT 10-Q
Notice of late quarterly filing
15 Dec 23
10-Q
2024 Q1
Quarterly report
20 Sep 23
NT 10-Q
Notice of late quarterly filing
14 Sep 23
10-K
2023 FY
Annual report
30 Aug 23
NT 10-K
Notice of late annual filing
31 Jul 23
10-Q
2023 Q3
Quarterly report
8 Mar 23
10-Q
2023 Q2
Quarterly report
9 Dec 22
Current reports
8-K
Departure of Directors or Certain Officers
14 Mar 24
8-K
Departure of Directors or Certain Officers
11 Dec 23
8-K
Changes in Registrant's Certifying Accountant
17 Nov 23
8-K
Entry into a Material Definitive Agreement
9 Mar 23
8-K
Entry into a Material Definitive Agreement
14 Feb 23
8-K
Entry into a Material Definitive Agreement
14 Dec 22
8-K
GPOPlus+ Appoints Chris Harter as a Member of the Board of Directors
28 Oct 22
8-K
This acquisition marks GPOX’s expansion into the profitable Direct-To-Consumer Vitamin and
13 Jul 22
8-K
Entry into a Material Definitive Agreement
20 Jan 22
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
10 Sep 21
Registration and prospectus
S-8
Registration of securities for employees
28 Mar 23
S-8
Registration of securities for employees
6 Jan 23
S-8
Registration of securities for employees
21 May 21
8-A12G
Registration of securities
21 May 21
424B3
Prospectus supplement
12 Dec 16
S-1/A
IPO registration (amended)
23 Nov 16
S-1/A
IPO registration (amended)
4 Nov 16
S-1/A
IPO registration (amended)
13 Oct 16
S-1
IPO registration
22 Sep 16
Proxies
No filings
Other
EFFECT
Notice of effectiveness
9 Dec 16
CORRESP
Correspondence with SEC
7 Dec 16
CORRESP
Correspondence with SEC
6 Dec 16
CORRESP
Correspondence with SEC
23 Nov 16
CORRESP
Correspondence with SEC
4 Nov 16
UPLOAD
Letter from SEC
27 Oct 16
CORRESP
Correspondence with SEC
13 Oct 16
UPLOAD
Letter from SEC
28 Sep 16